Emily Dutton
Research Subjects
Emily Dutton has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- David Dickson
HeartVets, Porthcawl, Wales, UK
2 shared publications J. Harris
2 shared publications- Joannna Dukes McEwan
Small Animal Teaching Hospital, Department of Small Animal Clinical Science, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Leahurst Campus, Chester High Road, Neston CH64 7TE UK
2 shared publications A. Boswood
The Royal Veterinary College, Cardiology Department, Hatfield, Hertfordshire AL9 7TA, UK
1 shared publication- A. Jakubczak
University of Liverpool, School of Veterinary Science, Institute of Infection, Veterinary and Ecological Sciences, Leahurst Campus, Neston, CH64 7TE UK; Cheshire Cardiology, The Old School House, Chester Rd, Northwich CW8 1LE UK
1 shared publication - Adrian Boswood
Department of Veterinary Clinical Sciences The Royal Veterinary College Hatfield Hertfordshire UK
1 shared publication
Latest Publications
- 15 November 2024
- Published by Wiley in Veterinary Record Case Reports
- Vol. 13 (1)
Paroxysmal and micro‐atrial fibrillation in a dog
Micro‐atrial fibrillation is a novel term in veterinary medicine. In human medical literature, it has been described as having characteristics of atrial fibrillation, but lasting less than 30 seconds with a sudden onset and offset, with episodes of five or more consecutive supraventricular premature complexes. This case report describes the clinical presentation, investigations and treatment of an 11‐year‐old Border terrier, and focuses on the pathophysiology of atrial fibrillation and discussion of case management. The aim of this case report is to make readers aware of the definition and diagnosis of micro‐atrial fibrillation.
- 15 November 2024
- Published by Wiley in Veterinary Record Case Reports
- Vol. 13 (1)
Paroxysmal and micro‐atrial fibrillation in a dog
Micro‐atrial fibrillation is a novel term in veterinary medicine. In human medical literature, it has been described as having characteristics of atrial fibrillation, but lasting less than 30 seconds with a sudden onset and offset, with episodes of five or more consecutive supraventricular premature complexes. This case report describes the clinical presentation, investigations and treatment of an 11‐year‐old Border terrier, and focuses on the pathophysiology of atrial fibrillation and discussion of case management. The aim of this case report is to make readers aware of the definition and diagnosis of micro‐atrial fibrillation.
- Open Access
Prevalence of Hypertrophic Cardiomyopathy and ALMS1 Variant in Sphynx Cats in New Zealand
Recently, hypertrophic cardiomyopathy (HCM) in Sphynx cats has been associated with a variant in the gene encoding Alström syndrome protein 1 (ALMS1). The primary aims of this study were to describe the prevalence of HCM in Sphynx cats in New Zealand, and to assess the association between HCM and the ALMS1 variant in this population. In this prospective study, 55 apparently healthy Sphynx cats from registered Sphynx breeders and pet owners in New Zealand were screened by a cardiologist. A total of 42 of these cats had a repeat cardiac examination after median 1.8 years (range: 1.6–2.2). The frequency of the ALMS1 variant was 70.9% (11 homozygous and 28 heterozygous). At the median age of 5.8 years (range: 2.4–13.1), the prevalence of HCM was 40% (20 out of 55 cats). Three cats with HCM died during the study with congestive heart failure. All three cats had focal but extensive myocardial ischemia or infarction at necropsy. The ALMS1 variant was not associated with the HCM diagnosis. In summary, HCM was common in the studied cohort, suggesting Sphynx cats are predisposed to this disease. While the ALMS1 variant was also frequently detected, it was not associated with HCM in this population.
Open AccessPrevalence of Hypertrophic Cardiomyopathy and ALMS1 Variant in Sphynx Cats in New Zealand
Recently, hypertrophic cardiomyopathy (HCM) in Sphynx cats has been associated with a variant in the gene encoding Alström syndrome protein 1 (ALMS1). The primary aims of this study were to describe the prevalence of HCM in Sphynx cats in New Zealand, and to assess the association between HCM and the ALMS1 variant in this population. In this prospective study, 55 apparently healthy Sphynx cats from registered Sphynx breeders and pet owners in New Zealand were screened by a cardiologist. A total of 42 of these cats had a repeat cardiac examination after median 1.8 years (range: 1.6–2.2). The frequency of the ALMS1 variant was 70.9% (11 homozygous and 28 heterozygous). At the median age of 5.8 years (range: 2.4–13.1), the prevalence of HCM was 40% (20 out of 55 cats). Three cats with HCM died during the study with congestive heart failure. All three cats had focal but extensive myocardial ischemia or infarction at necropsy. The ALMS1 variant was not associated with the HCM diagnosis. In summary, HCM was common in the studied cohort, suggesting Sphynx cats are predisposed to this disease. While the ALMS1 variant was also frequently detected, it was not associated with HCM in this population.
- Open Access
- 1 March 2021
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 35 (2) , 755-770
Accuracy of history, physical examination, cardiac biomarkers, and biochemical variables in identifying dogs with stage B2 degenerative mitral valve disease
Background: Treatment is indicated in dogs with preclinical degenerative mitral valve disease (DMVD) and cardiomegaly (stage B2). This is best diagnosed using echocardiography; however, relying upon this limits access to accurate diagnosis. Objectives: To evaluate whether cardiac biomarker concentrations can be used alongside other clinical data to identify stage B2 dogs. Animals: Client-owned dogs (n = 1887) with preclinical DMVD prospectively sampled in Germany, the United Kingdom, and the United States. Methods: Dogs that met inclusion criteria and were not receiving pimobendan (n = 1245) were used for model development. Explanatory (multivariable logistic regression) and predictive models were developed using clinical observations, biochemistry, and cardiac biomarker concentrations, with echocardiographically confirmed stage B2 disease as the outcome. Receiver operating characteristic curves assessed the ability to identify stage B2 dogs. Results: Age, appetite, serum alanine aminotransferase activity, body condition, serum creatinine concentration, murmur intensity, and plasma N-terminal propeptide of B-type natriuretic peptide (NT-proBNP) concentration were independently associated with the likelihood of being stage B2. The discriminatory ability of this explanatory model (area under curve [AUC], 0.84; 95% confidence interval [CI], 0.82-0.87) was superior to NT-proBNP (AUC, 0.77; 95% CI, 0.74-0.80) or the vertebral heart score alone (AUC, 0.76; 95% CI, 0.69-0.83). A predictive logistic regression model could identify the probability of being stage B2 (AUC test set, 0.86; 95% CI, 0.81-0.91). Conclusion and Clinical Importance: Our findings indicate accessible measurements could be used to screen dogs with preclinical DMVD. Encouraging at-risk dogs to seek further evaluation could result in a greater proportion of cases being appropriately managed.
- 1 March 2021
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 35 (2) , 755-770
Open AccessAccuracy of history, physical examination, cardiac biomarkers, and biochemical variables in identifying dogs with stage B2 degenerative mitral valve disease
Background: Treatment is indicated in dogs with preclinical degenerative mitral valve disease (DMVD) and cardiomegaly (stage B2). This is best diagnosed using echocardiography; however, relying upon this limits access to accurate diagnosis. Objectives: To evaluate whether cardiac biomarker concentrations can be used alongside other clinical data to identify stage B2 dogs. Animals: Client-owned dogs (n = 1887) with preclinical DMVD prospectively sampled in Germany, the United Kingdom, and the United States. Methods: Dogs that met inclusion criteria and were not receiving pimobendan (n = 1245) were used for model development. Explanatory (multivariable logistic regression) and predictive models were developed using clinical observations, biochemistry, and cardiac biomarker concentrations, with echocardiographically confirmed stage B2 disease as the outcome. Receiver operating characteristic curves assessed the ability to identify stage B2 dogs. Results: Age, appetite, serum alanine aminotransferase activity, body condition, serum creatinine concentration, murmur intensity, and plasma N-terminal propeptide of B-type natriuretic peptide (NT-proBNP) concentration were independently associated with the likelihood of being stage B2. The discriminatory ability of this explanatory model (area under curve [AUC], 0.84; 95% confidence interval [CI], 0.82-0.87) was superior to NT-proBNP (AUC, 0.77; 95% CI, 0.74-0.80) or the vertebral heart score alone (AUC, 0.76; 95% CI, 0.69-0.83). A predictive logistic regression model could identify the probability of being stage B2 (AUC test set, 0.86; 95% CI, 0.81-0.91). Conclusion and Clinical Importance: Our findings indicate accessible measurements could be used to screen dogs with preclinical DMVD. Encouraging at-risk dogs to seek further evaluation could result in a greater proportion of cases being appropriately managed.
- 17 April 2018
- Published by Wiley in Journal of Small Animal Practice
- Vol. 59 (8) , 455-464
An update on canine cardiomyopathies – is it all in the genes?
Dilated cardiomyopathy is the second most common cardiac disease in dogs and causes considerable morbidity and mortality. Primary dilated cardiomyopathy is suspected to be familial, and genetic loci have been associated with the disease in a number of breeds. Because it is an adult‐onset disease, usually with late onset, testing breeding dogs and bitches before breeding for a genetic mutation that could lead to dilated cardiomyopathy would be helpful to prevent disease. There is growing evidence that the genetic basis may be multigenic rather than monogenic in the majority of studied breeds. This review article describes the known genetic aspects of canine dilated cardiomyopathy and the implications of genetic tests on heart testing and the future of veterinary cardiology.
- 17 April 2018
- Published by Wiley in Journal of Small Animal Practice
- Vol. 59 (8) , 455-464
An update on canine cardiomyopathies – is it all in the genes?
Dilated cardiomyopathy is the second most common cardiac disease in dogs and causes considerable morbidity and mortality. Primary dilated cardiomyopathy is suspected to be familial, and genetic loci have been associated with the disease in a number of breeds. Because it is an adult‐onset disease, usually with late onset, testing breeding dogs and bitches before breeding for a genetic mutation that could lead to dilated cardiomyopathy would be helpful to prevent disease. There is growing evidence that the genetic basis may be multigenic rather than monogenic in the majority of studied breeds. This review article describes the known genetic aspects of canine dilated cardiomyopathy and the implications of genetic tests on heart testing and the future of veterinary cardiology.
- 11 October 2017
- Published by Wiley in Journal of Small Animal Practice
- Vol. 59 (3) , 167-173
Serum cardiac troponin I concentrations in dogs with generalised seizures
Objectives: To determine if serum cardiac troponin I concentrations – measured with both a first‐generation assay and a high‐sensitivity assay – were greater in dogs with generalised seizures than in controls and to identify clinical variables associated with cardiac troponin I concentration.Materials and Methods: Prospective study of 30 dogs with recent generalised seizures and 30 healthy controls. Serum cardiac troponin I concentration was measured using two commercially available assays, and the correlation of clinical factors with concentration was examined.Results: Serum concentrations of cardiac troponin I were higher in dogs that had recent seizures compared to controls when measured by both assays. The predictors most clearly associated with cardiac troponin I concentration were number of seizures and age. Both predictors were positively associated with increasing concentrations of troponin I.Clinical Significance: Serum cardiac troponin I concentration was significantly elevated in dogs that had recent generalised seizures when compared to controls, and concentrations were higher in dogs that experienced more seizures. This association may indicate that generalised seizures are associated with damage to the myocardium.
- 11 October 2017
- Published by Wiley in Journal of Small Animal Practice
- Vol. 59 (3) , 167-173
Serum cardiac troponin I concentrations in dogs with generalised seizures
Objectives: To determine if serum cardiac troponin I concentrations – measured with both a first‐generation assay and a high‐sensitivity assay – were greater in dogs with generalised seizures than in controls and to identify clinical variables associated with cardiac troponin I concentration.Materials and Methods: Prospective study of 30 dogs with recent generalised seizures and 30 healthy controls. Serum cardiac troponin I concentration was measured using two commercially available assays, and the correlation of clinical factors with concentration was examined.Results: Serum concentrations of cardiac troponin I were higher in dogs that had recent seizures compared to controls when measured by both assays. The predictors most clearly associated with cardiac troponin I concentration were number of seizures and age. Both predictors were positively associated with increasing concentrations of troponin I.Clinical Significance: Serum cardiac troponin I concentration was significantly elevated in dogs that had recent generalised seizures when compared to controls, and concentrations were higher in dogs that experienced more seizures. This association may indicate that generalised seizures are associated with damage to the myocardium.
- 1 February 2017
- Published by Elsevier in Journal of Veterinary Cardiology
- Vol. 19 (1) , 1-13
Serum cardiac troponin I in canine syncope and seizures
- 1 February 2017
- Published by Elsevier in Journal of Veterinary Cardiology
- Vol. 19 (1) , 1-13
Serum cardiac troponin I in canine syncope and seizures
- 7 February 2013
- Published by Wiley in Journal of Small Animal Practice
- Vol. 54 (4) , 213-218
Suspected exercise‐induced seizures in a young dog
A 12‐month‐old female neutered crossbreed was referred for investigation of seizure‐like episodes occurring only at intense exercise. Thorough medical, neurological and cardiac investigations were performed and excluded the most commonly known causes of seizure‐like activity. The dog was fitted with an ambulatory electrocardiography device and underwent another exercise‐induced seizure. The electrocardiogram during the episode revealed a sinus tachycardia at approximately 300 beats/minute. A video recording of the episode revealed generalised tonic clonic limb activity with jaw chomping and frothing at the mouth typical of seizure activity. Antiepileptic medications were not prescribed and the owner was advised not to exercise the dog intensely. The dog responded well and did not seizure after 12 months of mild‐moderate off‐lead exercise. As all the seizures in this case were triggered by intense physical activity, it is suggested that this may be a new form of reflex seizure activity.
- 7 February 2013
- Published by Wiley in Journal of Small Animal Practice
- Vol. 54 (4) , 213-218
Suspected exercise‐induced seizures in a young dog
A 12‐month‐old female neutered crossbreed was referred for investigation of seizure‐like episodes occurring only at intense exercise. Thorough medical, neurological and cardiac investigations were performed and excluded the most commonly known causes of seizure‐like activity. The dog was fitted with an ambulatory electrocardiography device and underwent another exercise‐induced seizure. The electrocardiogram during the episode revealed a sinus tachycardia at approximately 300 beats/minute. A video recording of the episode revealed generalised tonic clonic limb activity with jaw chomping and frothing at the mouth typical of seizure activity. Antiepileptic medications were not prescribed and the owner was advised not to exercise the dog intensely. The dog responded well and did not seizure after 12 months of mild‐moderate off‐lead exercise. As all the seizures in this case were triggered by intense physical activity, it is suggested that this may be a new form of reflex seizure activity.